| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ptc Therapeutics, Inc. (PTCT) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 394.1K | $32.01M | - | |
| CFO | 90.3K | $7.33M | - | |
| Other | 80.1K | $6.51M | - | |
| VP | 79.1K | $6.43M | - | |
| Other | 72.7K | $5.91M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | Klein Matthew B.55 | Chief Executive Officer | Sell | 7,792 | $50.11 | $390,457.09 | -1.4% | -8.3% | +40.3% | |
| Feb 20, 2025 | Golden Lee Scott45 | EVP &Chief Medical Officer | Sell | 1,757 | $50.11 | $88,045.61 | -1.1% | -8.3% | +40.3% | |
| Jan 8, 2025 | Utter Christine Marie58 | SVP, Chief Accounting Officer | Sell | 2,953 | $44.87 | $132,492.94 | -2.2% | -11.7% | +70.6% | |
| Jan 8, 2025 | Pauwels Eric62 | Chief Executive Officer | Sell | 3,735 | $44.86 | $167,550.66 | -2.1% | -11.7% | +70.6% | |
| Jan 8, 2025 | Klein Matthew B.55 | Chief Executive Officer | Sell | 4,544 | $44.90 | $204,007.28 | -0.8% | -11.7% | +70.6% | |
| Jan 8, 2025 | Golden Lee Scott45 | EVP &Chief Medical Officer | Sell | 2,008 | $44.84 | $90,036.40 | -1.3% | -11.7% | +70.6% | |
| Jan 8, 2025 | Boulding Mark Elliott55 | Exec. VP And CLO | Sell | 3,541 | $44.87 | $158,870.62 | -1.6% | -11.7% | +70.6% | |
| Jan 8, 2025 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sell | 2,979 | $44.87 | $133,674.30 | -1.3% | -11.7% | +70.6% | |
| Dec 31, 2024 | Klein Matthew B.55 | Chief Executive Officer | Sell | 8,279 | $45.16 | $373,879.64 | -3.7% | +12.9% | +68.3% | |
| Dec 3, 2024 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 95,908 | $52.37 | $5,022,334.27 | -12.9% | +5.1% | +50.6% |